Physician profile
Gregory Dearmond
NPI 1265651897
$6,602.75
in general payments reported to CMS, 2019-2025
9 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,268 · 2021: $1,484 · 2022: $1,717 · 2023: $248 · 2024: $351 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888 · Long Term Medical Supply Or Device Loan: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.23 |
| Long Term Medical Supply Or Device Loan | $245.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,391.80 | 2020-2025 | Da Vinci Surgical System |
| Davol INC. | $472.69 | 2022 | |
| Integra Lifesciences Corporation | $374.46 | 2025 | Integra, Micromatrix, Primatrix |
| Medtronic, INC. | $130.59 | 2024 | Kyphon Express II Kyphopak Tray |
| Pacira Pharmaceuticals Incorporated | $69.70 | 2023 | Exparel |
| Ethicon US, LLC | $54.48 | 2021-2022 | |
| Axonics, INC. | $46.14 | 2023 | Axonics |
| Tela Bio, INC. | $40.06 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $22.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dearmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.